Focal nodular hyperplasia

Focal Nodular Hyperplasia (FNH) is a benign condition of the liver that is often discovered incidentally during imaging studies for unrelated conditions. It is the second most common benign liver lesion, with Hemangioma being the most common. FNH is more frequently found in women and is often associated with the use of oral contraceptives.

Etiology

The exact cause of FNH is not known. However, it is believed to be associated with vascular malformations in the liver. Some studies suggest a possible link with the use of oral contraceptive pills, but this has not been definitively proven.

Clinical Presentation

Most patients with FNH are asymptomatic. When symptoms do occur, they are usually nonspecific and may include abdominal discomfort or fullness. Rarely, a large FNH can cause significant symptoms due to mass effect.

Diagnosis

FNH is often discovered incidentally during imaging studies for unrelated conditions. The diagnosis can usually be made based on characteristic imaging findings on Ultrasound, CT, or MRI. In some cases, a liver biopsy may be needed to confirm the diagnosis.

Treatment

No treatment is usually necessary for FNH, as it is a benign condition and does not increase the risk of liver cancer. In rare cases where the FNH is large and causing symptoms, surgical resection may be considered.

Prognosis

The prognosis for FNH is excellent. It does not increase the risk of liver cancer and does not usually require treatment.

Focal nodular hyperplasia Resources
Latest articles Most recent articles Ongoing trials	Wikipedia